Involvement of redox balance in in vitro osteoclast formation of RAW 264.7 macrophage cells in response to LPS

Innate Immunity

Volumn 21, Issue 2, 2015, Pages 194-202

  Odkhuu, Erdenezaya ^a,b   Koide, Naoki ^a   Tsolmongyn, Bilegtsaikhan ^a   Jambalganiin, Ulziisaikhan ^a   Naiki, Yoshikazu ^a   Komatsu, Takayuki ^a   Yoshida, Tomoaki ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

Author keywords

Glutathione; lipopolysaccharide; osteoclastogenesis; reactive oxygen species; redox state

Indexed keywords

GLUTATHIONE; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA; CULTURE MEDIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; FLOW CYTOMETRY; IMMUNOBLOTTING; MOUSE; MTT ASSAY; MULTINUCLEAR CELL; NONHUMAN; ONCOGENE C FOS; OSTEOCLASTOGENESIS; OXIDATION; OXIDATION REDUCTION STATE; PHENOTYPE; ANIMAL; C57BL MOUSE; CELL DEATH; CELL LINE; COMPARATIVE STUDY; IN VITRO STUDY; MACROPHAGE; MALE; METABOLISM; OSTEOCLAST; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

MURINAE;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIA; GLUTATHIONE; IN VITRO TECHNIQUES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84920486356     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425914524242     Document Type: Article

References (33)

1. Udagawa N, Takahashi N, Akatsu T, et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A. 1990 ; 87: 7260-7264
2. Roodman GD. Cell biology of the osteoclast. Exp Hematol. 1999 ; 27: 1229-1241
3. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev. 1992 ; 13: 66-80
4. Felix R, Cecchini MG, Hofstetter W, et al. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res. 1990 ; 5: 781-789
5. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998 ; 93: 165-176
6. Kobayashi N, Kadono Y, Naito A, et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 2001 ; 20: 1271-1280
7. Islam S, Hassan F, Tumurkhuu G, et al. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem Biophys Res Commun. 2007 ; 360: 346-351
8. Matsuo K, Galson DL, Zhao C, et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004 ; 279: 26475-26480
9. Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol. 2009 ; 10: 151-160
10. Zhuang L, Jung JY, Wang EW, et al. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo. Laryngoscope. 2007 ; 117: 841-847
11. Odkhuu E, Koide N, Haque A, et al. Inhibition of receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ). Immunol Lett. 2012 ; 142: 34-40
12. Noman AS, Koide N, Iftakhar EKI, et al. Retinoblastoma protein-interacting zinc finger 1 (RIZ1) participates in RANKL-induced osteoclast formation via regulation of NFATc1 expression. Immunol Lett. 2010 ; 131: 166-169
13. Mendjargal A, Odkhuu E, Koide N, et al. Pifithrin-alpha, a pharmacological inhibitor of p53, downregulates lipopolysaccharide-induced nitric oxide production via impairment of the MyD88-independent pathway. Int Immunopharmacol. 2013 ; 15: 671-678
14. Tumurkhuu G, Koide N, Dagvadorj J, et al. MnTBAP, a synthetic metalloporphyrin, inhibits production of tumor necrosis factor-alpha in lipopolysaccharide-stimulated RAW 264.7 macrophages cells via inhibiting oxidative stress-mediating p38 and SAPK/JNK signaling. FEMS Immunol Med Microbiol. 2007 ; 49: 304-311
15. Huh YJ, Kim JM, Kim H, et al. Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors. Cell Death Differ. 2006 ; 13: 1138-1146
16. Islam S, Hassan F, Tumurkhuu G, et al. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor. Microbiol Immunol. 2008 ; 52: 585-590
17. Ikeda F, Nishimura R, Matsubara T, et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 2004 ; 114: 475-484
18. Wagner EF, Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 2005 ; 208: 126-140
19. Sigma-Aldrich. Classical media & salts, http://www.sigmaaldrich.com/life-science/cell-culture/classical-media-salts.html (accessed 14 December 2013).
20. Zou W, Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res. 2002 ; 17: 1211-1218
21. Liu J, Wang S, Zhang P, et al. Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis. J Biol Chem. 2009 ; 284: 12512-12523
22. Takami M, Kim N, Rho J, Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol. 2002 ; 169: 1516-1523
23. Ji JD, Park-Min KH, Shen Z, et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol. 2009 ; 183: 7223-7233
24. Ishii J, Kitazawa R, Mori K, et al. Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF. J Cell Biochem. 2008 ; 105: 896-904
25. Takahashi N, Udagawa N, Kobayashi Y, Suda T. Generation of osteoclasts in vitro, and assay of osteoclast activity. Methods Mol Med. 2007 ; 135: 285-301
26. Carl VS, Gautam JK, Comeau LD, Smith MF. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression. J Leukoc Biol. 2004 ; 76: 735-742
27. Takayanagi H, Kim S, Koga T, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002 ; 3: 889-901
28. Kim H, Kim IY, Lee SY, Jeong D. Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts. FEBS Lett. 2006 ; 580: 5661-5665
29. Le Nihouannen D, Barralet JE, Fong JE, Komarova SV. Ascorbic acid accelerates osteoclast formation and death. Bone. 2010 ; 46: 1336-1343
30. Wilson M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci Prog. 1995 ; 78: 19-34
31. Nair SP, Meghji S, Wilson M, et al. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun. 1996 ; 64: 2371-2380
32. Silva MJ, Sousa LM, Lara VP, et al. The role of iNOS and PHOX in periapical bone resorption. J Dent Res. 2011 ; 90: 495-500
33. Fernbach SK, Poznanski AK. Case report 231. Acro-osteolysis presumably induced by septic shock. Skeletal Radiol. 1983 ; 10: 43-45